Adults (18-65), Geriatrics (65+)
Adults (18-65), Geriatrics (65+)
Internal Medicine, 2011
Medical Oncology, 2014
Perelman Center for Advanced Medicine
West Pavilion, 2nd Floor
3400 Civic Center Boulevard
Philadelphia, PA 19104
A facility of the Hospital of the University of Pennsylvania
The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.
Chao HC, Schonewolf CA, Tan EX, Swisher-McClure S, Ghiam AF, Weinstein GS, O’Malley BW, Chalian AA, Rassekh CH, Newman JG, Cohen RB, Bauml JM, Aggarwal C, Lin A, Lukens JN: The Impact of Treatment Package Time on Locoregional Control for HPV+ Oropharyngeal Squamous Cell Carcinoma Treated with Surgery and Postoperative (Chemo)Radiation Head Neck 41 (11): 3858-3868,2019.
Bauml JM, Mick R, Ciunci C, Aggarwal C, Davis C, Evans T, Deshpande C, Miller L, Patel P, Alley E, Knepley C, Mutale F, Cohen RB, Langer CJ: Pembrolizumab After Completion of Locally Ablative Therapy for Oligometastatic Non-Small Cell Lung Cancer: A Phase 2 Trial. JAMA Oncol. : 2019.
Ng TL, Smith DE, Mushtag R, Patil T, Dimou A, Yang S, Liu Q, Li X, Zhou C, Jones RT, Tu MM, Yan F, Bowman IA, Liu SV, Newkirk S, Bauml J, Doebele RC, Aisner DL, Gao D, Ren S, Camidge DR: ROS1 Gene Rearrangements are Associated with an Elevated Risk of Peridiagnosis Thromboembolic Events J Thorac Oncol. 14 (4): 596-605,2019.
Hammer M, Bagley S, Aggarwal C, Bauml J, Nachiappan AC, Simone CB 2nd, Langer C, Katz SI: Thoracic Imaging of Non-Small Cell Lung Cancer Treated with Anti-programmed Death Receptor-1 Therapy Curr Probl Diagn Radiol 48 (2): 142-147,2019.
Aggarwal C, Thompson JC, Black TA, Katz SI, Fan R, Yee SS, Chien AL, Evans TL, Bauml JM, Alley EW, Ciunci CA, Berman AT, Cohen RB, Lieberman DB, Majmundar KS, Savitch SL, Morrissette JJD, Hwang WT, Elenitoba-Johnson KSJ, Langer CJ, Carpenter EL.: Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in Metastatic Non-Small Cell Lung Cancer JAMA Oncol. 5 (2): 173-180,2019.
Bauml JM, Vinnakota R, Park YHA, Bates SE, Fojo T, Aggarwal C, DiStefano J, Knepley C, Limaye S, Mamtani R, Wisnivesky JP, Damjanov N, Langer CJ, Cohen RB, Sigel K: Cisplatin Versus Cetuximab with Definitive Concurrent Radiotherapy for Head and Neck Squamous Cell Carcinoma: an Analysis of Veteran’s Health Data Cancer 125 (3): 406-415,2019.
Horn L, Bauml J, Forde PM, Davis KL, Myall NJ, Sasane M, Dalal A, Culver K, Wozniak AJ, Baik CS, Mutebi A, Zhang P, Wakelee HA, Johnson BE: Real- World Treatment Patterns and Survival of Patients with BRAF V600-mutated Metastatic Non-Small Cell Lung Cancer. Lung Cancer 128 : 74-90,2019.
Aggarwal C, Cohen RB, Morrow MP, Kraynyak KA, Sylvester AJ, Knoblock DM, Bauml JM, Weinstein GS, Lin A, Boyer J, Sakata L, Tan S, Anton A, Dickerson K, Mangrolia D, Vang R, Dallas M, Oyola S, Duff S, Esser M, Kumar R, Weiner D, Csiki I, Bagarazzi ML: Immunotherapy Targeting HPV 16/18 Generates Potent Immune Responses in HPV-Associated Head and Neck Cancer Clin Cancer Res. 25 (1): 110-124,2019.
Bange E, Marmarelis ME, Hwang WT, Yang YX, Thompson JC, Rosenbaum J, Bauml JM, Ciunci C, Alley EW, Cohen RB, Langer CJ, Carpenter E, Aggarwal C: Impact of KRAS and TP53 Co-Mutations on Outcomes After First-Line Systemic Therapy Among Patients with STK11-Mutated Advanced Non-Small Cell Lung Cancer JCO Precis Oncol. 3 : 2019.
Romero SAD, Brown JC, Bauml JM, Hay JL, Li QS, Cohen RB, Mao JJ: Barriers to physical activity: a study of academic and community cancer survivors with pain J Cancer Surviv. 12 (6): 744-752,2018.
Division of Hematology OncologyPerelman Center for Advanced MedicineSouth Pavilion, Floor 10Office #10-1403400 Civic Center Blvd
Phone: (215) 614-1853
Patient appointments: 800-789-7366
Proton therapy is a non–invasive, incredibly precise cancer treatment that uses a beam of protons moving at very high speeds to destroy cancer cells.
Our experienced cancer nurses and referral staff are here to help. Call 800-789-7366 (PENN) or complete an online request.
Learn more about the benefits of translational research at Penn Medicine.